老年患者种植体存留率与边缘骨水平的5-11年回顾性研究
结果显示种植体存留率为95.4%,平均边缘骨水平为1.24毫米,最大边缘骨丧失≥5毫米者仅占0.5%。年龄对边缘骨水平呈现轻微保护效应,提示高龄不应被视为种植治疗的限制因素。
要点
- 65岁以上患者种植体5-11年存留率达95.4%,支持种植治疗可行性。
- 平均边缘骨水平为1.24毫米,最大边缘骨丧失≥5毫米者仅0.5%。
- 年龄增长对边缘骨水平有轻微保护作用,非种植治疗限制因素。
核心结论
- 在65岁及以上患者中,种植体5-11年存留率为95.4%,平均边缘骨水平为1.24毫米,最大边缘骨丧失≥5毫米者仅0.5%,提示高龄不应视为种植治疗的限制因素。
主要发现
- 种植体存留率为95.4%,其中早期失败4枚、晚期失败6枚。
- 平均边缘骨水平为1.24±0.9毫米,最大边缘骨丧失为1.48±1.0毫米。
- 最大边缘骨丧失<2毫米、2-5毫米、≥5毫米的种植体分别占70.7%、28.8%、0.5%。
关键数值与推荐
- 平均边缘骨水平1.24±0.9毫米,最大边缘骨丧失1.48±1.0毫米。
- 最大边缘骨丧失≥5毫米的种植体占0.5%。
临床怎么用
- 对于65岁及以上患者,种植治疗可获得高存留率和良好边缘骨稳定性,不应仅因年龄而排除种植适应症。
- 临床随访中应关注边缘骨水平变化,但高龄本身并非种植失败的高危因素。
局限性
- 回顾性研究设计可能存在选择偏倚和信息偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: To evaluate implant survival and marginal bone levels (MBLevel ) at least 5 years after implant installation in patients ≥65 years old. METHODS: Patient records were screened retrospectively for the following inclusion criteria: (1) ≥65 years of age at the time of implant installation, and (2) ≥5-year radiographic follow-up or registered implant loss. Association between patient- and implant-related data with radiographically assessed data [i.e. implant survival, mean MBLevel (i.e. average of mesial and distal level) and maximum marginal bone loss (i.e. either mesial or distal loss; maximum MBLoss )] were statistically evaluated by mixed effects multi-level regression models. RESULTS: Two-hundred-eighteen implants in 74 patients were included with a mean follow-up of 6.2 years (range: 5 to 10.7 years); four early and six late implant losses have been registered (implant survival rate: 95.4%). Mean MBLevel and maximum MBLoss was 1.24 ± 0.9 mm and 1.48 ± 1.0 mm, respectively. Maximum MBLoss < 2 mm, 2 to 5 mm and ≥5 mm was found in 70.7, 28.8 and 0.5% of the implants, respectively. For both, mean MBLevel and maximum MBLoss , age presented a slightly protective effect (mean MBLevel : Coef. -0.041, p = .016; maximum MBLoss : Coef. -0.045, p = .014). CONCLUSION: The high implant survival rate (95.4%), low mean MBLevel (1.24 mm) and low frequency of maximum MBLoss ≥ 5 mm (0.5%) observed herein after 5 to 11 years follow-up suggest that older age should not be considered as a limiting factor for implant treatment.
引用
- Etöz O, Bertl K, Kukla E, et al. How old is old for implant therapy in terms of implant survival and marginal bone levels after 5-11 years? Clin Oral Implants Res. 2021. PMID: 33368735. doi:10.1111/clr.13704
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。